Cargando…

Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis

Lessons were learned with trans women who participated (as volunteers and investigators) in trials of HIV pre-exposure prophylaxis (PrEP). Trans women are not men. Compared with men who have sex with men, trans women trial participants were more likely to be involved with transactional sex, had more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grant, Robert M., Sevelius, Jae M., Guanira, Juan V., Aguilar, Jana Villayzan, Chariyalertsak, Suwat, Deutsch, Madeline B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:	Supplement Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969062/ https://www.ncbi.nlm.nih.gov/pubmed/27429187 http://dx.doi.org/10.1097/QAI.0000000000001090

Ejemplares similares

HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
por: Deutsch, Madeline B., et al.
Publicado: (2015)

Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California
por: Sevelius, Jae M., et al.
Publicado: (2021)

Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial
por: Solomon, Marc M., et al.
Publicado: (2014)

Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand
por: Yang, Daniel, et al.
Publicado: (2013)

The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
por: Solomon, Marc M., et al.
Publicado: (2016)

The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices
por: Sevelius, Jae M, et al.
Publicado: (2016)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices
por: Radix, Asa, et al.
Publicado: (2016)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
por: Solomon, Marc M., et al.
Publicado: (2014)

Integrated and Gender-Affirming Transgender Clinical Care and Research
por: Reisner, Sari L., et al.
Publicado: (2016)

Evaluation of a pre‐exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens
por: Ramautarsing, Reshmie A, et al.
Publicado: (2020)

A comparison of attitudes and knowledge of pre-exposure prophylaxis (PrEP) between hospital and Key Population Led Health Service providers: Lessons for Thailand’s Universal Health Coverage implementation
por: Rayanakorn, Ajaree, et al.
Publicado: (2022)

HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study
por: Colby, Donn, et al.
Publicado: (2015)

High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina
por: Zalazar, Virginia, et al.
Publicado: (2016)

Integrating HIV pre‐exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study
por: Bórquez, Annick, et al.
Publicado: (2020)

Experiences of Pre-Exposure Prophylaxis Stigma, Social Support, and Information Dissemination Among Black and Latina Transgender Women Who Are Using Pre-Exposure Prophylaxis
por: Brooks, Ronald A., et al.
Publicado: (2019)

Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study
por: Konda, Kelika A., et al.
Publicado: (2022)

1285. PrEP Acceptability, Uptake, and Adherence Among Young Men Who Have Sex with Men and Transgender Women in PrEP Demonstration Project, Chiang Mai, Thailand
por: Kaewpoowat, Quanhathai, et al.
Publicado: (2019)

Transgender Person and Pre-Exposure Prophylaxis for HIV: A Renal Dilemma
por: Sheikh, Abu Baker, et al.
Publicado: (2021)

Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa
por: Price, Joan T., et al.
Publicado: (2016)

HIV Incidence, Risk Factors, and Motivation for Biomedical Intervention among Gay, Bisexual Men, and Transgender Persons in Northern Thailand
por: Chariyalertsak, Suwat, et al.
Publicado: (2011)

Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges
por: Veloso, Valdilea G, et al.
Publicado: (2015)

Long‐term retention in pre‐exposure prophylaxis care among men who have sex with men and transgender women in the United States
por: Chan, Philip A, et al.
Publicado: (2019)

Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention
por: Morton, Jennifer F., et al.
Publicado: (2017)

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
por: Carballo-Diéguez, Alex, et al.
Publicado: (2017)

The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil
por: Luz, Paula M, et al.
Publicado: (2018)

Inclusion as illusion: erasing transgender women in research with MSM
por: Poteat, Tonia C, et al.
Publicado: (2021)

The Helping Networks of Transgender Women Living with HIV
por: Hill, Miranda, et al.
Publicado: (2023)

“Entre Nosotras:” a qualitative study of a peer-led PrEP project for transgender latinas
por: Zamudio-Haas, Sophia, et al.
Publicado: (2023)

Behavioral Interventions to Prevent HIV Transmission and Acquisition for Transgender Women: A Critical Review
por: Garofalo, Robert, et al.
Publicado: (2016)

Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention
por: Walters, Suzan M., et al.
Publicado: (2021)

Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature
por: Baldwin, Aleta, et al.
Publicado: (2021)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW)
por: Defechereux, Patricia A., et al.
Publicado: (2015)

Design Issues in Transgender Studies
por: Hughes, James P., et al.
Publicado: (2016)

Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study
por: Hiransuthikul, Akarin, et al.
Publicado: (2019)

Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions
por: Cattani, Vitória Berg, et al.
Publicado: (2023)

Impact along the HIV pre‐exposure prophylaxis “cascade of prevention” in western Kenya: a mathematical modelling study
por: Bershteyn, Anna, et al.
Publicado: (2020)

Determinants of Pre-exposure Prophylaxis (PrEP) Implementation in Transgender Populations: A Qualitative Scoping Review
por: Zamantakis, Alithia, et al.
Publicado: (2022)

“It’s behaviors, not identity”: Attitudes and beliefs related to HIV risk and pre-exposure prophylaxis among transgender women in the Southeastern United States
por: Van Gerwen, Olivia T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ck7t6lkoqhrng08jh1tf3811g